PD
IMRX icon

Point72 (DIFC)’s Immuneering IMRX Stock Holding History

Point72 (DIFC)’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16
Closed -$54 – 1510
2025
Q2 		$54 Buy
+16
New +$27 ﹤0.01% 1491
2025
Q1 		– Sell
-16
Closed -$35 – 1859
2024
Q4 		$35 Hold
16
– – ﹤0.01% 1463
2024
Q3 		$40 Sell
16
-4,967
-100% -$7.22K ﹤0.01% 1376
2024
Q2 		$6.38K Buy
+4,983
New +$8.19K ﹤0.01% 1355

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 (DIFC)'s IMRX Position: Q3 2025 in Review

Point72 (DIFC) sold out of Immuneering (IMRX) in Q3 2025, closing a stake of 16 shares — an estimated $54 sold.

Point72 (DIFC) first reported a position in IMRX in Q2 2024 and held it in 4 quarters. The position peaked at $6.38K in Q2 2024. 68 funds tracked by Wall St. Rank hold IMRX as of Q3 2025.

  • Point72 (DIFC) reported no remaining Immuneering position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 16 Immuneering shares in Q3 2025, an estimated $54.
  • Point72 (DIFC) first reported a position in Immuneering in Q2 2024 and held it in 4 quarters.
  • Point72 (DIFC)'s Immuneering position peaked at $6.38K in Q2 2024.
  • 68 funds tracked by Wall St. Rank held Immuneering as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.